You are here

AusPAR: Vedolizumab (rch)

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

11 December 2014
AusPAR Details
AusPAR
Active Ingredient
Vedolizumab (rch)
Product Name
Entyvio / Kynteles
Sponsor
Takeda Pharmaceuticals Australia Pty Ltd
Submission Number
PM-2013-01102-1-1
Submission Type
New biological entity
Decision
Approved
AusPAR Date
17 November 2014
Publication Date

11 December 2014